Myriad Genetics

📢 We're at the American Society of Human Genetics (ASHG) Annual Meeting in #Denver! #teamMyriad is excited to present #newresearch in genetics and participate in insightful discussions with leaders in human genetics. We'll be showcasing four posters and presenting a podium talk this week, highlighting our commitment to advancing global expertise in prenatal and cancer care. Here's where you can find us: 📅 Wed., Nov. 6: Validation of Fetal and Maternal Recessive Disease Genotyping with FirstGene; Enhancing Carrier Screening with 39 Additional ACMG-Recommended Genes 📅 Thu., Nov. 7: Validation of Spinal Muscular Atrophy (SMA) and Hb Barts Screening Using FirstGene 📅 Fri., Nov. 8: Association of Polygenic-Based Breast Cancer Risk Prediction with Patient Management 🎤 Sat., Nov. 9: Genetic Information in Breast Cancer Risk Assessment and Screening See you there! #ASHG2024 #precisionmedicine #genomics #event #ASHG

Heading to Colorado Springs next week for #NEICongress? ⛰️ Don’t miss GeneSight's Nicholas Haynes presentation on healthcare resource utilization and medication patterns in patients with #majordepressivedisorder, happening November 8th from 3:35 to 4:30 p.m. We'll see you there! 🧬

We are proud to sponsor our partner, the Arab Society of Genetic Counselors (ASGC), as they explore the current status of rare diseases in Arab populations - as well as the available testing and diagnostic strategies - in this upcoming virtual conference. Register below and be part of the conversation on November 9th! #event #geneticcounseling #healthcareprofessionals #genetictesting

Join us for a comprehensive #webinar on HRD testing with MyChoice HRD Plus, taking place Tuesday, November 5th at 9 AM CT. This renowned medical panel will provide insights into the MyChoice HRD Plus test and will be available for a Q&A session to answer your questions. Webinar highlights include: 👉 Gaining insights into the HRD test validated in phase III studies 1-3 for ovarian cancer patients, 👉 Overseeing the testing experience with this HRD test in past years, 👉 Understanding the clinical implications of HRD testing in #ovariancancer patients. 🔵 Register now: https://lnkd.in/gbzwVwHk #hrd #innovation #healthcareprofessionals

Excited to see our very own Adrianne D. recognized by Entrepreneurial Outlook as one of the 10 Most Influential Women in Tech, 2024! Read her full story via the link below: #teamMyriad #informationtechnology #leadership #innovation

Today, we announced we will hold our third quarter earnings conference call on Thursday, November 7, 2024 at 4:30 PM ET. Learn more: https://lnkd.in/gwsjkirf

More than a test, MyRisk®'s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management. Learn more at www.getmyrisk.com. #hereditarycancer #breastcancer #genetictesting #healthcareprofessionals

For women with a strong family history of breast cancer, understanding your risk isn’t just about peace of mind—it’s about taking actionable steps toward prevention with early detection and effective treatment. Learn more about knowing your risk and planning for your future at https://lnkd.in/gtkpWJFr #BreastCancerAwareness #EarlyDetection #HealthEmpowerment

As Election Day draws closer, Americans' anxiety and/or depression around the #election remains significantly elevated, according to the latest results from the GeneSight Mental Health Monitor: Special Election Series. This 3-part nationwide survey has been following the impact of election season on mental health, among the ongoing mental health crisis in the U.S. If you're struggling, don't hesitate to reach out to your healthcare provider for support. Read more findings from the survey at https://lnkd.in/gdMs-FAX #mentalhealth #anxiety

👩💼💼 With 1 in 8 women facing a #breastcancer diagnosis, early detection and comprehensive insights to drive more effective treatment are critical. This #BreastCancerAwarenessMonth, we encourage healthcare providers to offer germline testing to their patients by utilizing tests such as our MyRisk® Hereditary Cancer Test. By identifying a patient’s hereditary cancer risk, MyRisk not only helps in shaping their care but also empowers family members to understand their own potential risk. Together, we’re giving patients and their families a chance for healthier futures through precision medicine. 🌟 https://lnkd.in/geYptXk7 #breastcancer #MyRisk #precisionmedicine #genetictesting #hereditarycancer